Clinical Trial Update: Severe and Cerebral Malaria Investigated Through Host Metabolomics

View source ↗

Summary

A University of Oxford study investigating severe and cerebral malaria using host metabolomics has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Malaria
• Malaria

Snippet

Sponsor: University of Oxford | Conditions: Severe Malaria | Status: COMPLETED